Literature DB >> 18809556

Comparison of serum and whole-blood specimens for the detection of Candida DNA in critically ill, non-neutropenic patients.

L Metwally1, D J Fairley1, P V Coyle1, R J Hay2, S Hedderwick3, B McCloskey4, H J O'Neill1, C H Webb1, R McMullan1.   

Abstract

In contrast to the multitude of studies on fungal PCR assay methods, little work has been reported evaluating Candida PCR performance when using whole blood compared with serum in candidaemic patients. Here, a comparison of the performance of whole-blood and serum specimens using a set of real-time PCR Candida species assays is described. Specimens were collected prospectively from non-neutropenic adults who were recruited to a diagnostic clinical trial, the primary purpose of which was to verify the performance of the assays using serum; in all, 104 participants also had whole-blood specimens submitted for analysis in addition to the serum specimen. Of these participants, 10 had laboratory-confirmed candidaemia and 94 were categorized as being 'unlikely' to have invasive Candida infection. PCR results from the whole-blood specimens are presented here and compared with the results from serum specimens in this subgroup among whom both specimen types were obtained contemporaneously. All participants with candidaemia were PCR-positive from serum samples; however, only seven were PCR-positive from whole blood. All specimens from patients in the 'unlikely' category were PCR-negative in both types of specimen. Moreover, DNA extraction from serum required 1 h; extraction from whole blood required approximately 3 h. These data tentatively suggest that, overall, serum is an appropriate specimen for Candida PCR for detection of candidaemia in non-neutropenic adults.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18809556     DOI: 10.1099/jmm.0.2008/002444-0

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  6 in total

1.  Comparison of whole blood, serum, and plasma for early detection of candidemia by multiplex-tandem PCR.

Authors:  Anna Lau; Catriona Halliday; Sharon C-A Chen; E Geoffrey Playford; Keith Stanley; Tania C Sorrell
Journal:  J Clin Microbiol       Date:  2009-12-30       Impact factor: 5.948

2.  Advances and prospects for molecular diagnostics of fungal infections.

Authors:  Stéphane Bretagne
Journal:  Curr Infect Dis Rep       Date:  2010-11       Impact factor: 3.725

Review 3.  Molecular and nonmolecular diagnostic methods for invasive fungal infections.

Authors:  Marios Arvanitis; Theodora Anagnostou; Beth Burgwyn Fuchs; Angela M Caliendo; Eleftherios Mylonakis
Journal:  Clin Microbiol Rev       Date:  2014-07       Impact factor: 26.132

Review 4.  PCR-based diagnosis of human fungal infections.

Authors:  Prasanna D Khot; David N Fredricks
Journal:  Expert Rev Anti Infect Ther       Date:  2009-12       Impact factor: 5.091

5.  PCR-detectable Candida DNA exists a short period in the blood of systemic candidiasis murine model.

Authors:  Zheng-Xin He; Hui-Hai Zhao; Fu-Kun Wang
Journal:  Open Life Sci       Date:  2020-09-06       Impact factor: 0.938

6.  A quick and low-cost PCR-based assay for Candida spp. identification in positive blood culture bottles.

Authors:  Hemílio Xafranski; Analy S A Melo; Antonia M Machado; Marcelo R S Briones; Arnaldo L Colombo
Journal:  BMC Infect Dis       Date:  2013-10-07       Impact factor: 3.090

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.